{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:54:27Z","timestamp":1766159667907,"version":"3.40.3"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec027\">\n<jats:title>Background<\/jats:title>\n<jats:p>Africa accounts for two-thirds of the global HIV infection and a disproportionate burden is in sub-Saharan Africa. In 2017, the Zambian government launched the U\u2009=\u2009U campaign which has proven to be key in the prevention of HIV. However, there is a paucity of empirical evidence on the magnitude of detectable viral load in Choma district. This study aimed to estimate the proportion of detectable viral load and identify the associated factors among adults living with HIV receiving antiretroviral therapy (ART) in Choma District, Zambia.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec028\">\n<jats:title>Methods<\/jats:title>\n<jats:p>This was a cross-sectional study among adults aged 15 years and older on ART \u2265\u200912 months. Sociodemographic, clinical and laboratory data were collected through a structured questionnaire and data collection form for secondary data from medical records. Detectable Viral load (primary outcome) and Virological failure (secondary outcome) were defined as viral load (VL) &gt;\u2009200cp\/ml and VL &gt;\u20091000cp\/ml respectively. The data collected was then analysed using STATA version XII. Descriptive statistics, chi-square test, Wilcoxon rank sum test, and logistic regression were the statistical methods used.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec029\">\n<jats:title>Results<\/jats:title>\n<jats:p>There was a total of 448 participants. The median (interquartile range (IQR)) age was 41 years (32, 49) of whom 284 (63.2%) were females. The prevalence of detectable and virological failure were 10.3% (n\u2009=\u200946; 95% confidence interval (CI) 7.6, 13.5) and 5.4% (n\u2009=\u200924; 95%CI 3.5, 7.9) respectively. In multivariable analysis, detectable VL was significantly associated with young age (16 \u2013 24 years) (odds ratio (OR) 3.38; 95%CI 1.04, 10.94; p\u2009=\u20090.042), no formal education (OR 3.32; 95%CI 1.06, 10.40; p\u2009=\u20090.040), missing medication (OR 3.99; 95%CI 1.83, 8.73; p\u2009=\u20090.001) and problem taking medication (OR 2.74; 95%CI 1.10; 6.84; p\u2009&lt;\u20090.030); while factors associated with virological failure were being in age group 16 \u2013 24 years (OR 7.28; 95%CI 1.62, 32.68, p\u2009=\u20090.009), male gender (OR 3.12; 95%CI 1.25, 7.76; p\u2009=\u20090.014), Missing taking medication (OR 8.28; 95%CI 2.59, 26.40; p\u2009&lt;\u20090.001) and taking dolutegravir-based regimen with zidovudine\/lamivudine backbone (OR 17.80 95% CI 2.29 - 132.31; p\u2009=\u20090.005).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec030\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Detectable VL and virological failure were prevalent among adults receiving ART for \u2265\u200912 months and were significantly associated with sociodemographic and clinical factors. There is a need for targeted interventions, especially among young people and males to accelerate the attaining of the last 95 of the UNAIDS target; which is imperative in the prevention of HIV transmission. Qualitative research which aims to get an in-depth understanding of why men and young people do not attain optimal viral suppression is encouraged.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0320571","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T19:22:22Z","timestamp":1743708142000},"page":"e0320571","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of detectable viral load and its associated factors among adult patients receiving ART in Choma District, Zambia"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1818-4990","authenticated-orcid":true,"given":"Macwani","family":"Mutukwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Kaonga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Mfula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musa M.","family":"Mwansa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1385-0998","authenticated-orcid":true,"given":"Benson M.","family":"Hamooya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"pone.0320571.ref001","author":"WHO"},{"key":"pone.0320571.ref002","author":"WHO"},{"key":"pone.0320571.ref003","author":"UNAIDS"},{"key":"pone.0320571.ref004","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ssmph.2017.02.001","article-title":"Adult mortality in sub-saharan Africa, Zambia: Where do adults die?","volume":"3","author":"VH Chisumpa","year":"2017","journal-title":"SSM Popul Health"},{"key":"pone.0320571.ref005","author":"ZAMPHIA"},{"key":"pone.0320571.ref006","author":"UNAIDS"},{"issue":"2","key":"pone.0320571.ref007","doi-asserted-by":"crossref","first-page":"61","DOI":"10.22158\/csm.v2n2p61","article-title":"The Science of Undetectable Equals Un-Transmittable Plays out in Real Life a Clinical Case Report","volume":"2","author":"AT Dickens","year":"2019","journal-title":"CSM"},{"key":"pone.0320571.ref008","author":"Zamstats"},{"issue":"1","key":"pone.0320571.ref009","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12879-020-05124-1","article-title":"Prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with HIV in a minority area in China: a population-based study","volume":"20","author":"D Yuan","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"11","key":"pone.0320571.ref010","doi-asserted-by":"crossref","first-page":"e0142923","DOI":"10.1371\/journal.pone.0142923","article-title":"Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study","volume":"10","author":"G Leierer","year":"2015","journal-title":"PLoS One"},{"issue":"07","key":"pone.0320571.ref011","doi-asserted-by":"crossref","first-page":"108","DOI":"10.9790\/0853-15076108121","article-title":"Factors Associated with Virologic Failure Amongst Adults on Antiretroviral Therapy in Nyanza Region, Kenya.","volume":"15","author":"RKA Sang","year":"2016","journal-title":"IOSR"},{"key":"pone.0320571.ref012","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13256-015-0557-0","article-title":"Very early virological failure and drug resistance mutations in a woman on antiretroviral therapy in Eastern Cape, South Africa: a case report","volume":"9","author":"OO Sogbanmu","year":"2015","journal-title":"J Med Case Rep"},{"key":"pone.0320571.ref013","first-page":"153","article-title":"Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case-control study","volume":"9","author":"B Bayu","year":"2017","journal-title":"HIV AIDS (Auckl)"},{"key":"pone.0320571.ref014","first-page":"44","article-title":"Incidence of virological failure and associated factors among adult HIV-positive patients on first line antiretroviral therapy regimen, Central Ethiopia","author":"T Endebu","year":"2018","journal-title":"International Journal of Health Policy and Management"},{"issue":"7","key":"pone.0320571.ref015","doi-asserted-by":"crossref","first-page":"e036223","DOI":"10.1136\/bmjopen-2019-036223","article-title":"Determinants of virological failure among adults on first-line highly active antiretroviral therapy at public health facilities in Kombolcha town, Northeast, Ethiopia: a case-control study","volume":"10","author":"HM Meshesha","year":"2020","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0320571.ref016","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s12879-018-3372-6","article-title":"Virological failure among adolescents on ART, Harare City, 2017- a case-control study","volume":"18","author":"Z Sithole","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"10","key":"pone.0320571.ref017","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1007\/s10461-022-03610-y","article-title":"Burden and Associated Factors of Virological Failure Among People Living with HIV in Sub-Saharan Africa: A Systematic Review and Meta-Analysis","volume":"26","author":"CD Agegnehu","year":"2022","journal-title":"AIDS Behav"},{"issue":"8","key":"pone.0320571.ref018","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/QAD.0000000000001068","article-title":"Socioeconomic status and response to antiretroviral therapy in high-income countries: a literature review","volume":"30","author":"LS Burch","year":"2016","journal-title":"AIDS"},{"issue":"8","key":"pone.0320571.ref019","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/QAD.0000000000001777","article-title":"Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies\/ml among illicit drug users","volume":"32","author":"MC Kennedy","year":"2018","journal-title":"AIDS"},{"issue":"3","key":"pone.0320571.ref020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jpids\/pit008","article-title":"Changes in Advanced Immunosuppression and Detectable HIV Viremia Among Perinatally HIV-Infected Youth in the Multisite United States HIV Research Network","volume":"2","author":"AL Agwu","year":"2013","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"8","key":"pone.0320571.ref021","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/jmv.25680","article-title":"Ethnicity as predictor of immune reconstitution among Malaysian HIV-positive patients treated with highly active antiretroviral therapy","volume":"92","author":"II Mohamad Isa","year":"2020","journal-title":"J Med Virol"},{"key":"pone.0320571.ref022","author":"M Mv","year":"1999"},{"issue":"2","key":"pone.0320571.ref023","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/09540120802001705","article-title":"Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders","volume":"21","author":"CA Mellins","year":"2009","journal-title":"AIDS Care"},{"key":"pone.0320571.ref024","author":"WHO"},{"key":"pone.0320571.ref025","author":"UNAIDS"},{"key":"pone.0320571.ref026","author":"WHO"},{"issue":"11","key":"pone.0320571.ref027","doi-asserted-by":"crossref","first-page":"e25631","DOI":"10.1002\/jia2.25631","article-title":"Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys","volume":"23","author":"AD Haas","year":"2020","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"pone.0320571.ref028","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12879-017-2428-3","article-title":"Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015","volume":"17","author":"L Bulage","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"3","key":"pone.0320571.ref029","doi-asserted-by":"crossref","first-page":"e25474","DOI":"10.1002\/jia2.25474","article-title":"Patterns of detectable viral load in a cohort of HIV-positive adolescents on antiretroviral therapy in South Africa","volume":"23","author":"R Sher","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"pone.0320571.ref030","doi-asserted-by":"crossref","first-page":"32947","DOI":"10.1038\/srep32947","article-title":"Rapid HIV Viral Load Suppression in those Initiating Antiretroviral Therapy at First Visit after HIV Diagnosis","volume":"6","author":"M Hoenigl","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"pone.0320571.ref031","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1007\/s10461-021-03296-8","article-title":"Changing Knowledge and Attitudes Towards HIV Treatment-as-Prevention and \u201cUndetectable\u2009=\u2009Untransmittable\u201d: A Systematic Review","volume":"25","author":"J Bor","year":"2021","journal-title":"AIDS Behav"},{"issue":"1","key":"pone.0320571.ref032","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4102\/curationis.v45i1.2312","article-title":"Viral suppression among adolescents on HIV treatment in the Sedibeng District, Gauteng province","volume":"45","author":"S Mabizela","year":"2022","journal-title":"Curationis"},{"issue":"Suppl 3","key":"pone.0320571.ref033","doi-asserted-by":"crossref","first-page":"21528","DOI":"10.7448\/IAS.20.4.21528","article-title":"Transition from paediatric to adult care of adolescents living with HIV in sub-Saharan Africa: challenges, youth-friendly models, and outcomes","volume":"20","author":"DL Dahourou","year":"2017","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"pone.0320571.ref034","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4102\/sajhivmed.v21i1.1077","article-title":"Retention in care for adolescents who were newly initiated on antiretroviral therapy in the Cape Metropole in South Africa","volume":"21","author":"B van Wyk","year":"2020","journal-title":"South Afr J HIV Med"},{"issue":"10","key":"pone.0320571.ref035","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1080\/09540120902730054","article-title":"We never thought this would happen: transitioning care of adolescents with perinatally acquired HIV infection from pediatrics to internal medicine","volume":"21","author":"T Vijayan","year":"2009","journal-title":"AIDS Care"},{"key":"pone.0320571.ref036","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.92898","article-title":"Gender Differences in Human Immunodeficiency Virus (HIV) Disease Progression and Treatment Outcomes","author":"F Mosha","year":"2021","journal-title":"AIDS Updates - Recent Advances and New Perspectives"},{"issue":"3","key":"pone.0320571.ref037","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1086\/341249","article-title":"Does patient sex affect human immunodeficiency virus levels?","volume":"35","author":"M Gandhi","year":"2002","journal-title":"Clin Infect Dis"},{"key":"pone.0320571.ref038","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/1471-2458-10-291","article-title":"Effect of improved access to antiretroviral therapy on clinical characteristics of patients enrolled in the HIV care and treatment clinic, at Muhimbili National Hospital (MNH), Dar es Salaam, Tanzania","volume":"10","author":"SF Mugusi","year":"2010","journal-title":"BMC Public Health"},{"issue":"1","key":"pone.0320571.ref039","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/inthealth\/ihw050","article-title":"Sex disparities in outcomes among adults on long-term antiretroviral treatment in northern Nigeria","volume":"9","author":"BM Musa","year":"2017","journal-title":"Int Health"},{"issue":"12","key":"pone.0320571.ref040","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1097\/QAD.0000000000001553","article-title":"Sexual partnership age pairings and risk of HIV acquisition in rural South Africa","volume":"31","author":"A Akullian","year":"2017","journal-title":"AIDS"},{"issue":"1","key":"pone.0320571.ref041","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41564-023-01530-8","article-title":"Longitudinal population-level HIV epidemiologic and genomic surveillance highlights growing gender disparity of HIV transmission in Uganda","volume":"9","author":"M Monod","year":"2024","journal-title":"Nat Microbiol"},{"key":"pone.0320571.ref042","doi-asserted-by":"crossref","first-page":"905773","DOI":"10.3389\/fimmu.2022.905773","article-title":"Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches","volume":"13","author":"JA Moran","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"pone.0320571.ref043","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2989\/16085906.2023.2276897","article-title":"Interventions to improve young men\u2019s utilisation of HIV-testing services in KwaZulu-Natal, South Africa: perspectives of young men and health care providers","volume":"22","author":"S Ndlovu","year":"2023","journal-title":"African Journal of AIDS Research"},{"key":"pone.0320571.ref044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/9247451","article-title":"Viral Suppression and Its Associated Factors in HIV Patients on Highly Active Antiretroviral Therapy (HAART): A Retrospective Study in the Ho Municipality, Ghana","author":"SY Lokpo","year":"2020","journal-title":"AIDS Research and Treatment"},{"key":"pone.0320571.ref045","unstructured":"Dlamini TN. Faculty of Health Sciences Department of Community Medicine."},{"issue":"11","key":"pone.0320571.ref046","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1080\/09540121003693514","article-title":"Literacy, education and adherence to antiretroviral therapy in The Gambia","volume":"22","author":"A Hegazi","year":"2010","journal-title":"AIDS Care"},{"key":"pone.0320571.ref047","first-page":"29","article-title":"Predictors of Viral Load Status Over Time Among HIV Infected Adults Under HAART in Zewditu Memorial Hospital, Ethiopia: A Retrospective Study","volume":"15","author":"A Agegn Gwadu","year":"2023","journal-title":"HIV AIDS (Auckl)"},{"issue":"1","key":"pone.0320571.ref048","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12981-021-00400-9","article-title":"Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala","volume":"18","author":"DW Ort\u00ed z","year":"2021","journal-title":"AIDS Res Ther"},{"issue":"7","key":"pone.0320571.ref049","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1089\/aid.2021.0106","article-title":"Predictive Factors of Detectable Viral Load in HIV-Infected Patients","volume":"38","author":"A Bouchard","year":"2022","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"pone.0320571.ref050","doi-asserted-by":"crossref","first-page":"ofw089","DOI":"10.1093\/ofid\/ofw089","article-title":"A Single Quantifiable Viral Load Is Predictive of Virological Failure in Human Immunodeficiency Virus (HIV)-Infected Patients on Combination Antiretroviral Therapy: The Austrian HIV Cohort Study","volume":"3","author":"G Leierer","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"pone.0320571.ref051","author":"\u201cMinistry of Health \u2013 MOH.\u201d"},{"issue":"40","key":"pone.0320571.ref052","doi-asserted-by":"crossref","first-page":"e30624","DOI":"10.1097\/MD.0000000000030624","article-title":"Standardized enhanced adherence counseling for improved HIV viral suppression among children and adolescents in Homa Bay and Turkana Counties, Kenya","volume":"101","author":"RO Masaba","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"pone.0320571.ref053","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/QAI.0000000000001036","article-title":"Single Viral Load Measurements Overestimate Stable Viral Suppression Among HIV Patients in Care: Clinical and Public Health Implications","volume":"73","author":"G Marks","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"pone.0320571.ref054","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12981-021-00393-5","article-title":"Acquired HIV drug resistance and virologic monitoring in a HIV hyper-endemic setting in KwaZulu-Natal Province, South Africa","volume":"18","author":"B Chimukangara","year":"2021","journal-title":"AIDS Res Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0320571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T19:24:10Z","timestamp":1743708250000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0320571"}},"subtitle":[],"editor":[{"given":"Ibrahim","family":"Jahun","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0320571","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]}}}